Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

R.A. Adams, A.M. Meade, M.T. Seymour, Richard Wilson, A. Madi, D. Fisher, S.L. Kenny, E. Kay, E. Hodgkinson, M. Pope, P. Rogers, H. Wasan, S. Falk, S. Gollins, T. Hickish, E.M. Bessell, D. Propper, J.M. Kennedy, R. Kaplan, T.S. Maughan

Research output: Contribution to journalArticlepeer-review

177 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial'. Together they form a unique fingerprint.

Medicine & Life Sciences